Skip to content

Voltage-gated potassium channel regulatory subunit KCNG2 (KCNG2)

Homo sapiens — UniProt Q9UJ96

Gene: KCNG2Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Voltage-gated potassium channel regulatory subunit KCNG2 (KCNG2) is a protein from Homo sapiens identified by UniProt accession Q9UJ96, 466 residues long. MolForge cross-references it against 0 known binders and 85 disease associations.

  • UniProt accession: Q9UJ96; gene symbol KCNG2.
  • Organism: Homo sapiens.
  • Length: 466 amino acids.
  • Top disease associations (Open Targets): multiple sclerosis, Myasthenia gravis and schizophrenia.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameVoltage-gated potassium channel regulatory subunit KCNG2
UniProt accessionQ9UJ96
GeneKCNG2
OrganismHomo sapiens
Length466 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (85)

Diseases linked to this target (Open Targets).

  • multiple sclerosis · score 0.59
  • Myasthenia gravis · score 0.57
  • schizophrenia · score 0.47
  • Muscle weakness · score 0.46
  • small cell carcinoma · score 0.46
  • secondary progressive multiple sclerosis · score 0.43
  • self reported educational attainment · score 0.42
  • age at first sexual intercourse measurement · score 0.39
  • smoking status measurement · score 0.38
  • leukocyte count · score 0.37

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q9UJ96-F1alphafoldPREDICTED79.54—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q9UJ96.

Amino-acid sequence (466 residues)

MEPWPCSPGG GGGTRARHVI INVGGCRVRL AWAALARCPL ARLERLRACR GHDDLLRVCD DYDVSRDEFF FDRSPCAFRA IVALLRAGKL RLLRGPCALA FRDELAYWGI DEARLERCCL RRLRRREEEA AEARAGPTER GAQGSPARAL GPRGRLQRGR RRLRDVVDNP HSGLAGKLFA CVSVSFVAVT AVGLCLSTMP DIRAEEERGE CSPKCRSLFV LETVCVAWFS FEFLLRSLQA ESKCAFLRAP LNIIDILALL PFYVSLLLGL AAGPGGTKLL ERAGLVLRLL RALRVLYVMR LARHSLGLRS LGLTMRRCAR EFGLLLLFLC VAMALFAPLV HLAERELGAR RDFSSVPASY WWAVISMTTV GYGDMVPRSL PGQVVALSSI LSGILLMAFP VTSIFHTFSR SYSELKEQQQ RAASPEPALQ EDSTHSATAT EDSSQGPDSA GLADDSADAL WVRAGR

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with KCNG2?

The strongest Open Targets associations for KCNG2 are multiple sclerosis, Myasthenia gravis, schizophrenia, Muscle weakness and small cell carcinoma.

How long is the KCNG2 protein?

The Homo sapiens KCNG2 protein (UniProt Q9UJ96) is 466 amino acids long.

Browse: Targets: K · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Voltage-gated potassium channel regulatory subunit KCNG2 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ9UJ96
GeneKCNG2
OrganismHomo sapiens
Length466
Binders0
Diseases85
View on UniProt